Stock screener

INCY

Conviction 80HealthcareScan · Tue, Sep 8, 2026
INCY$124.41-1.85%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 1.19M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
INCYTE CORPSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.incyte.com ↗
Price124.41
Change-1.85%
Gap-2.72%
Rel volume0.69×
Avg volume1.18M
Avg $ vol148.16M
SMA 20125.36
SMA 50121.02
SMA 200104.82
Price vs 50+2.80%
Price vs 200+18.69%
MA stackbullish
50/200 cross—
Supertrendup · 118.54
RSI (14)51
MACD hist-0.46
MACD crossbear · 6d
Stoch %K / %D30 / 54
ADX (14)20
+DI / −DI28 / 25
RSI divergence—
MACD divergence—
ATR %+2.76%
ADR %2.42%
52w high129.93
52w low81.66
From 52w high-4.25%
Above 52w low+52.35%
New 52w highNo
SqueezeOff
Bollinger width9.65%
%B0.42
Donchian pos51.74%
Donchian high130.80
Donchian low117.56
AVWAP (52w high)124.14
vs AVWAP high+0.22%
AVWAP (52w low)102.53
vs AVWAP low+21.34%
OBV trendFlat
Chaikin MF (20)0.18
Today vs 20d0.69×
Avg vol (14d)1.19M
Avg vol (20d)1.18M
Avg $ vol (20d)148.16M
Market cap24.85B
RS 3m (vs SPY)+19.38%
RS 6m (vs SPY)+17.57%
RS line new highNo
Trend template8/8
Technical rank77.2
1 week+0.97%
1 month+3.19%
3 months+23.62%
6 months+28.13%
1 year+43.59%
YTD+22.67%
P/E19.32
P/B4.42
P/S4.83
P/FCF18.21
EPS6.41
Div yield—
ROE22.88%
ROA17.53%
Debt/Eq0.18
Current3.68
EV/EBITDA13.93
Gross margin—
Net margin25.03%
Rev growth21.22%
EPS growth3844.96%
Price target130.79
Target upside5.13%
Analyst ratingBuy
Institutional110.85%
Ent. value22.4B
Revenue1.27B
Net income303.33M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out199.78M
Employees2.84K
ListedWed, Nov 3, 1993
Free float166.24M
Float %83.5%
Short interest9.39M
Days to cover6.7d
Short volume46.1%
Squeeze score40 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.80 vs $1.76
Last surprise+59.1% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank77.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance131.70
Support115.14
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INCY · 1 recent

All disclosures →
MemberSideAmount
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INCY · 4 buys · 6 sells

InsiderSideShares
Basi Ramitpal K
EVP, Human Resources · Common Stock · 2026-08-25
Tax504
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-08-19
Sell10.8K
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-08-12
Sell10.8K
Mayes Patrick A
EVP & Chief Scientific Officer · Employee Stock Option (right to buy) · 2026-08-05
Exercise2.21K
CAGNONI PABLO J
President, Global Head of R&D · Common Stock · 2026-08-05
Sell10.64K
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-08-05
Exercise2.21K
Mayes Patrick A
EVP & Chief Scientific Officer · Common Stock · 2026-08-05
Sell2.21K
Heeson Lee
EVP, Head of Incyte Intl · Employee Stock Option (right to buy) · 2026-07-23
Grant15.42K
Heeson Lee
EVP, Head of Incyte Intl · Performance Shares · 2026-07-23
Grant13.5K
Morrissey Michael James
EVP, Head of Tech. Operations · Employee Stock Option (right to buy) · 2026-07-23
Grant6.43K

SEC filings

EDGAR filings in INCY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.